MyoKardia (MYOK) PT Raised to $65 at BMO Capital
Tweet Send to a Friend
BMO Capital raised its price target on MyoKardia (NASDAQ: MYOK) to $65.00 (from $45.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
